October 31, 2022
The eighth annual Infant Health Policy Summit welcomed health care providers, parents,policymakers, advocates and other stakeholders to explore how policy…
October 25, 2022
Patients with rare diseases often struggle to get a timely diagnosis and proper treatment.
October 24, 2022
On 13 July 2022, the Alliance for Patient Access’ Rare Diseases Working Group hosted a virtual discussion on primary hyperoxaluria type 1.
October 18, 2022
Spilt beverages. Dropped food. Difficulty dressing. Embarrassment.
October 13, 2022
Tezepelumab is a novel severe asthma treatment that was approved for clinician administration in late 2021. After a few months on the market, however, several Medicare Administrative Contractors made the unprecedented decision to place tezepelumab, a biologic approved for physician administration, on the Self-Administered Drug list.
October 11, 2022
Vaccines and preventive monoclonal antibodies are two different types of immunization. While they function differently, they both serve the same…
September 21, 2022
Following the success of the November 2021 focus groups for IgG4-RD patients, the Alliance for Patience Access hosted another focus group to capture additional insights.
September 20, 2022
The U.S. Food and Drug Administration’s standard approval process for new drugs delivers patients the safest, most advanced medications in the world.
August 18, 2022
Hepatitis C is a paradox of American health care. The medical community has never been better equipped to diagnose, cure and prevent this potentially fatal liver disease.
July 29, 2022
The fifth annual Cardiovascular Health Policy Summit, held on June 9, welcomed policy
experts, patient advocates and health care providers to address patients’ pressing
needs and explore policy solutions that will improve the lives of Americans with
cardiovascular disease.
